NorthWest Biotherapeutics Inc (NWBO)

[john1045]

This is from the link you embedded in your post on Commercialization....great reminder Chris.

Commercial Issues
DCVax
-L produced by NWBT is at present the only product
of its kind in a phase III trial. If the results of the trial translate
into approval of the product, then demand is likely to be a
significant consideration. Therefore an international network of
manufacturing sites will be required to enhance NWBT’s infrastructure
and ensure its capacity to address this demand.

Message in reply to:

Wow thank you RK great summary!

http://www.tandfonline.com/doi/pdf/10.4161/hv.29276

Well here we all wait two years later from this article which states...

"Final approval of DCVax-L will await the outcome of the phase III trial although if interim analysis results are favorable, then an early approval of the product may well be achieved."